CIK 0001439725
- Non-accelerated filer
- Smaller reporting company
BIODESIX INC
Sign in to watch- Ticker
- BDSX
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203986492
- Phone
- +1 303-417-0500
- Business address
- 919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 4,347,840 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion President & CEO acquired 26,120 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion CFO, Sec'y & Treasurer acquired 17,289 shares (option exercise)
- 4 Exercise or conversion Director acquired 217,400 shares (option exercise)
- 4 Open-market sale Chief Accounting Officer sold 244 shares at $1.48 ($361)
- 4 Open-market sale Chief Development Officer sold 434 shares at $1.48 ($642)
- 4 Open-market sale Chief Commercial Officer sold 468 shares at $1.48 ($692)
- 4 Open-market sale President & CEO sold 3,764 shares at $1.48 ($5,569)
- 4 Open-market sale CFO, Sec'y & Treasurer sold 980 shares at $1.48 ($1,450)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 17 · 336 filings